Biochemical consequences of adenosine deaminase inhibition in vivo. Differential effects in acute and chronic T cell leukemia.
D058892:Adenosine Deaminase Inhibitors; D000255:Adenosine Triphosphate / Q000172:deficiency; D043383:Adenosylhomocysteinase; D000368:Aged; D003070:Coformycin / Q000031:analogs & derivatives / Q000494:pharmacology; D003838:Deoxyadenine Nucleotides / Q000378:metabolism; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D006867:Hydrolases / Q000037:antagonists & inhibitors; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000201:enzymology* / Q000378:metabolism; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D015649:Pentostatin; D013601:T-Lymphocytes / Q000201:enzymology
D058892:Adenosine Deaminase Inhibitors; D003838:Deoxyadenine Nucleotides; D003070:Coformycin; D015649:Pentostatin; D000255:Adenosine Triphosphate; D006867:Hydrolases; D043383:Adenosylhomocysteinase; D009700:Nucleoside Deaminases